COM902 is a human IgG4 monoclonal antibody (mAb) targeting TIGIT, designed to boost antitumor immune responses. It is applicable in research related to multiple myeloma, solid tumors, and colorectal cancer. The recommended isotype control is IgG4-lambda.
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
